市场见解

The Novonix share price has tumbled 25% so far in December. What’s going wrong?

Novonix shares have been under pressure in December. What’s going on?
The post The Novonix share price has tumbled 25% so far in December. What’s going wrong? appeared first on The Motley Fool Australia. –

It hasn’t been an all too merry December for the Novonix Ltd (ASX: NVX) share price this year. Shares in the battery materials and technology company have sunk around 25% in value since the beginning of the month.

In contrast, the Novonix share price rallied ~12.5% in December last year. Since then, the company’s shares have gone on to be the best performing of the entire S&P/ASX 200 Index (ASX: XJO) in the last year — rising more than 750% in the past 12 months. However, it appears the heat has recently died off on this red hot stock.

Let’s take a look at what might be hampering this electrifying company in December.

Valuations pulled into question on Novonix share price

After hitting an all-time high of $12.47 on 2 December 2021, the Novonix share price violently tumbled 27% the following day. Perhaps the most unsettling characteristic of this price decline was that it occurred without any announcement from the company.

The reversal in the battery testing and anode material developer followed an article in The Australian Financial Review a day earlier. The article highlighted the disparity between the market capitalisation and revenue of many ‘green’ investment plays.

In the case of Novonix, it held a valuation of around $6 billion on revenues of $5.3 million prior to its fall. This reflected a price-to-sales (P/S) ratio of ~1,132 times. For comparison, another ASX-listed company developing green technologies, Calix Ltd (ASX: CXL), currently trades on a P/S ratio of approximately 50 times.

As we have covered previously, the publication noted there seemed to be “dozens, or perhaps hundreds” of lithium or green-orientated companies that will be driven more by sentiment than financials over the next year.

Since the fall on 3 December, the Novonix share price has recovered around 10%. However, the company’s shares are still a significant 39% away from their 52-week high.

Board members increase holdings

The latest news from Novonix, published to the ASX, involves two “change of director’s interest” notices. According to the notices, executive director Robert Natter and non-executive chair Anthony Bellas exercised their performance rights to acquire more Novonix shares last week.

Furthermore, both Natter and Bellas acquired 200,000 Novonix shares following the exercising of their performance rights. At the current Novonix share price, that equates to $1.806 million worth of shares each.

Finally, the company’s shares remain up 642% year-to-date. At the time of writing, Novonix is trading at $9.02 per share.

The post The Novonix share price has tumbled 25% so far in December. What’s going wrong? appeared first on The Motley Fool Australia.

Should you invest $1,000 in Novonix right now?

Before you consider Novonix, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Novonix wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Here are the top 10 ASX shares today

Novonix (ASX:NVX) share price shrugs off this morning’s gains to plunge 4% lower

Is the bubble bursting? Novonix (ASX:NVX) share price plunges 27%

Novonix (ASX:NVX) share price combats today’s selloff to remain up 44% in a month. Here’s why

These were the 5 best performing ASX shares in November

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!